TIS 0.00% 0.0¢ tissue therapies limited

relax regarding ce and website, page-15

  1. 2,630 Posts.
    lightbulb Created with Sketch. 4
    Once sales start the company will have been considerably de-risked in the eyes of many investors.

    This increases our options considerably - Eg. loan capital would be attractive at current interest rates - esp. if raised in Europe. And professional investors keen for a stake could well make us an offer too good to refuse. Etc.

    We would be foolish not to raise capital (on the right terms) as there are many other avenues to explore for VitroGro commercialisation - waiting for sufficient organic cash flow to emerge before commencing these would be a waste.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.